Brief: Ryvu Therapeutics Q2 Net Loss Narrows To 28.5 Mln Zlotys
Sept 13 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q2 NET LOSS 28.5 MILLION ZLOTYS VERSUS LOSS OF 36.9
MILLION
ZLOTYS YEAR AGO
* Q2 OPERATING REVENUE 15.0 MILLION ZLOTYS VERSUS 7.3
MILLION
ZLOTYS YEAR AGO
* Q2 OPERATING LOSS 31.6 MILLION ZLOTYS VERSUS LOSS OF 38.1
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM3mz8vJa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project